Cardiovascular Therapy and Prevention, 2006; 5(1)

Original articles

Epidemiology and Prevention

PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN GAS INDUSTRY WORKERS: COMPARISON WITH MONICA STUDY RESULTS; 10-YEAR RISK DISTRIBUTION FOR SEVERE CORONARY COMPLICATIONS IN CORONARY HEART DISEASE-FREE PATIENTS

V.A. Aksenov, A.N. Tin"kov
Medical Service, "Orenburggazprom Ltd.".
Orenburg, Russia

Abstract

EPIDEMIOLOGICAL CHARACTERISTIC OF CARDIOVASCULAR RISK FACTORS AND DIET PATTERNS IN SCHOOLCHILDREN

L.V. El"garova, A.A. El"garov, A.M. Kardangusheva
Kh. M. Berbekov Kabardino-Balkar State University
.
Nal"chik, Russia.

Abstract

Arterial hypertension

MAIN RESULTS OF THE RUSSIAN TRIAL "ALTAIR"

E.V. Shlyakhto, A.O. Conrady, Yu.V. Sviryaev, on behalf of the Research Team*
V.A. Almazov Research Institute of Cardiology, Russian Federal Agency of Health and Social Development.
St. Petersburg, Russia.

Abstract

FIXED DOSE COMBINATION OF PERINDOPRIL WITH INDAPAMIDE IN PRIMARY PREVENTION OF CEREBROVASCULAR COMPLICATIONS AMONG PATIENTS WITH METABOLIC SYNDROME AND ARTERIAL HYPERTENSION

V.B. Mychka, K.M. Mamyrbaeva, V.P. Masenko, V.B. Sergienko, I.E. Chazova
A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, Russian Federal Agency of Health and Social Development.
Moscow, Russia.

Abstract

AN IMIDAZOLINE RECEPTOR AGONIST, MOXONIDINE, IN OPTIMIZATION OF ARTERIAL HYPERTENSION TREATMENT AMONG POSTMENOPAUSAL WOMEN

A.B. Bakhshaliev, G.M. Sabzalieva, T.Sh. Dzhakhangirov
Dzh. Abdullaev Cardiology Research Institute. Baku, Azerbaijan.

Abstract

MOEXIPRIL EFFECTS ON LUNG FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

N.V. Ivanova1, V.I. Lazareva2, G.N. Kovan"ko1
1St. Petersburg Continuous Medical Education Academy, 2Pokrov City Hospital.
St. Petersburg, Russia.

Abstract

Ishemic heart desease

STABLE ANGINA PECTORIS: POPULATION TRENDS, DIAGNOSTICS, SECONDARY PREVENTION, AND ANTIANGINAL THERAPY

R.G. Oganov1, V.K. Lepakhin2, S.B. Fitilev2, A.M. Levin2, I.I. Shkrebneva2, Yu.Yu. Titarova2, M.K. Doronkina2
1State Research Center for Preventive Medicine, Russian Federal Agency of Health and Social Development,
2Russian University of People
Тs Friendship. Moscow, Russia

Abstract

HIGH-DEFINITION ELECTROCARDIOGRAPHY, HEART RATE VARIABILITY AND QT INTERVAL ASSESSMENT IN CORONARY HEART DISEASE DIAGNOSTICS DURING PROFESSIONAL MEDICAL EXAMINATION OF RAILROAD WORKERS.

A.E. Radzevich, V.V. Popov, M.Yu. Knyazeva
Мoscow State Medico-Stomatological University; Central Hospital No. 6, "Russian Railroads Ltd.".
Moscow, Russia.

Abstract

GENDER-SPECIFIC PROGNOSIS IN ACUTE CORONARY SYNDROME

R.T. Saygitov1, M.G. Glezer2, D.P. Sementsov2, N.A. Malygina1
1Russian Research Institute of Gerontology, Russian Federal Agency of Health and Social Development,
2City Clinical Hospital No. 59.
Moscow, Russia.

Abstract

PRE-INFARCTION ANGINA AND ISCHEMIC PRE-CONDITIONING ROLE IN CORONARY RESERVE PROTECTION DURING EARLY POST-INFARCTION PERIOD

A.P. Ivanov, T.S. Gornostaeva, I.A. Elgardt
Tver Medical Academy
, Tver Cardiology Dispanser. Tver, Russia

Abstract

PHYSICAL WORKING CAPACITY AND AUTONOMOUS REGULATION BALANCE IN MYOCARDIAL INFARCTION PATIENTS DURING LONG-TERM OUT-PATIENT REHABILITATION

G.G. Efremushkin, A.G. Akimochkina, A.A. Efremushkina
Altay State Medical University
.
Barnaul, Russia.

Abstract

RESULTS OF CORONARY ANGIOPLASTY AND CORONARY STENTING DURING THE FIRST POST-INTERVENTION YEAR

R.T. Libenzon, V.G. Seyidov, V.V. Evsyukov, I.V. Lubchuk1
Vladivostok State Medical University, 1Military and Navy Clinical Hospital of the Pacific Navy Forces.
Vladivostok, Russia.

Abstract

Review articles

MODERN VIEWS ON BIOLOGICAL NO EFFECTS AND ITS ROLE IN CARDIOVASCULAR PATHOLOGY PATHOGENESIS

S.S. Parshina
Saratov State Medical University
. Saratov, Russia.

Abstract

PHYSICAL REHABILITATION AND ENDOTHELIAL DYSFUNCTION IN CORONARY HEART DISEASE

V.A. Margazin, A.S. Noskova1
K.D. Ushinsky Yaroslavl State Pedagogical University, 1Yaroslavl State Medical Academy.
Yaroslavl, Russia.

Abstract

PHARMACOGENETICS OF HMG-COA REDUCTASE INHIBITORS (STATINS): PERSPECTIVES OF INDIVIDUALIZED, GENOTYPE-BASED THERAPY

D.A. Sychev1,2, A.V. Semenov1, G.V. Ramenskaya1,2, I.V. Ignatyev2, S.V. Paukov2, V.G. Kukes1,2
1I.M. Sechenov Moscow Medical Academy;
2Clinical Pharmacology Institute, Scientific Center for Medical Agents Expertise, Ministry of Health of the Russian Federation.
Moscow, Russia

Abstract

Press Release

New medication for stable angina treatment has been approved by European Agency for the Evaluation of the Medicinal Products (EMEA)

Cardiovascular Therapy and Prevention, 2006; 5(1): 105-106 

Information

Russian National Cardiology Congress. Information Letter

Cardiovascular Therapy and Prevention, 2006; 5(1): 107-109

Announcement for authors

Cardiovascular Therapy and Prevention, 2006; 5(1): 110

Яндекс.Метрика